×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

HIDA Scan Market

ID: MRFR/MED/3793-HCR
206 Pages
Rahul Gotadki
October 2025

HIDA Scan Market Research Report Information By Product (Radiopharmaceuticals, Gamma Camera), Indication (Cholecystitis, Bile Duct Obstruction, Biliary Atresia, Postoperative Complications and Assessment of Liver Transplant) and End User - Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

HIDA Scan Market Infographic
Purchase Options

HIDA Scan Market Summary

As per MRFR analysis, the HIDA Scan Market Size was estimated at 0.2224 USD Billion in 2024. The HIDA Scan industry is projected to grow from 0.2473 in 2025 to 0.715 by 2035, exhibiting a compound annual growth rate (CAGR) of 11.2 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The HIDA Scan Market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements are enhancing the accuracy and efficiency of HIDA scans, thereby improving diagnostic outcomes.
  • North America remains the largest market for HIDA scans, while the Asia-Pacific region is emerging as the fastest-growing market.
  • The radiopharmaceuticals segment dominates the market, whereas the HIDA scan segment is witnessing rapid growth due to rising demand for early diagnosis.
  • Key market drivers include the increasing prevalence of liver diseases and advancements in nuclear medicine, which are propelling market expansion.

Market Size & Forecast

2024 Market Size 0.2224 (USD Billion)
2035 Market Size 0.715 (USD Billion)
CAGR (2025 - 2035) 11.2%

Major Players

GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Hologic (US), Fujifilm Holdings (JP), Lantheus Medical Imaging (US)

HIDA Scan Market Trends

The HIDA Scan Market is currently experiencing a notable evolution, driven by advancements in nuclear medicine and increasing awareness regarding the importance of early diagnosis in various hepatic conditions. This imaging technique, which utilizes radiopharmaceuticals to visualize liver function and biliary excretion, appears to be gaining traction among healthcare providers. The growing prevalence of liver diseases, coupled with an aging population, suggests a rising demand for effective diagnostic tools. Furthermore, the integration of innovative technologies, such as artificial intelligence, into imaging processes may enhance the accuracy and efficiency of HIDA scans, potentially transforming patient outcomes. In addition, the HIDA Scan Market is likely to benefit from ongoing research and development efforts aimed at improving radiopharmaceutical formulations. These advancements may lead to enhanced imaging quality and reduced radiation exposure for patients. Moreover, the increasing focus on personalized medicine could further propel the market, as tailored diagnostic approaches become more prevalent. As healthcare systems worldwide continue to prioritize patient-centered care, the HIDA Scan Market is poised for growth, reflecting a broader trend towards more precise and effective diagnostic methodologies.

Technological Advancements

The HIDA Scan Market is witnessing a surge in technological innovations, particularly in imaging techniques and radiopharmaceuticals. Enhanced imaging modalities are likely to improve diagnostic accuracy, while new formulations may reduce side effects and enhance patient safety.

Rising Demand for Early Diagnosis

There is an increasing emphasis on early detection of liver diseases, which is driving the demand for HIDA scans. As healthcare providers recognize the importance of timely intervention, the market is expected to expand, catering to a growing patient population.

Integration of Artificial Intelligence

The incorporation of artificial intelligence into the HIDA Scan Market appears to be a transformative trend. AI technologies may streamline imaging processes, improve interpretation accuracy, and facilitate better clinical decision-making, thereby enhancing overall patient care.

HIDA Scan Market Drivers

Growing Geriatric Population

The expanding geriatric population is a significant factor influencing the HIDA Scan Market. Older adults are more susceptible to various health conditions, including liver dysfunction and biliary diseases, which necessitate accurate diagnostic imaging. As the global population ages, the demand for medical imaging services, particularly HIDA scans, is expected to rise. Statistics indicate that the proportion of individuals aged 65 and older is steadily increasing, leading to a higher prevalence of age-related health issues. This demographic shift presents a substantial opportunity for the HIDA Scan Market, as healthcare providers seek effective diagnostic tools to manage the health of elderly patients. Consequently, the market is likely to expand in response to the growing need for specialized imaging services tailored to this population.

Rising Healthcare Expenditure

An increase in healthcare expenditure across various regions is driving the HIDA Scan Market. As governments and private sectors allocate more resources to healthcare, there is a corresponding rise in the availability and accessibility of advanced diagnostic services. This trend is particularly evident in developing economies, where investments in healthcare infrastructure are on the rise. Enhanced funding allows for the procurement of advanced imaging technologies, including HIDA scan equipment, which improves diagnostic capabilities. Furthermore, as patients become more aware of their health and seek timely medical interventions, the demand for HIDA scans is likely to grow. The HIDA Scan Market stands to benefit from this upward trend in healthcare spending, as it facilitates the adoption of innovative diagnostic solutions.

Advancements in Nuclear Medicine

Innovations in nuclear medicine technology are transforming the HIDA Scan Market. The development of more sophisticated radiopharmaceuticals and imaging equipment enhances the accuracy and efficiency of HIDA scans. These advancements allow for better visualization of liver function and biliary tract disorders, which is essential for accurate diagnosis. The market has witnessed a shift towards hybrid imaging techniques, combining HIDA scans with other modalities such as CT and MRI, which improves diagnostic capabilities. As healthcare facilities invest in state-of-the-art imaging technologies, the HIDA Scan Market is likely to experience substantial growth. The integration of these advanced technologies not only improves patient outcomes but also increases the overall demand for HIDA scans in clinical settings.

Increasing Prevalence of Liver Diseases

The rising incidence of liver diseases, including hepatitis and cirrhosis, is a crucial driver for the HIDA Scan Market. As liver-related ailments become more common, the demand for diagnostic imaging techniques, such as HIDA scans, is likely to increase. According to recent health statistics, liver diseases account for a significant percentage of global morbidity and mortality. This trend necessitates advanced imaging solutions to facilitate early diagnosis and effective treatment planning. The HIDA Scan Market is poised to benefit from this growing need, as healthcare providers seek reliable methods to assess liver function and detect abnormalities. Furthermore, the increasing awareness of liver health among the population may lead to more individuals seeking diagnostic services, thereby propelling market growth.

Increased Focus on Preventive Healthcare

The growing emphasis on preventive healthcare is a notable driver for the HIDA Scan Market. As healthcare systems shift towards proactive management of health, the demand for early diagnostic tools, such as HIDA scans, is likely to increase. Preventive healthcare strategies aim to identify potential health issues before they escalate, and HIDA scans play a crucial role in this approach, particularly for liver and biliary tract assessments. The rising awareness among patients regarding the importance of regular health check-ups further fuels this trend. Consequently, healthcare providers are increasingly incorporating HIDA scans into routine diagnostic protocols, thereby enhancing the market's growth potential. This focus on prevention aligns with broader public health initiatives aimed at reducing the burden of chronic diseases.

Market Segment Insights

By Product: Radiopharmaceuticals (Largest) vs. HIDA Scan (Fastest-Growing)

In the HIDA Scan Market, the radiopharmaceuticals segment holds the largest market share, driven by their crucial role in diagnostic imaging. These compounds are fundamental for the identification of various liver and biliary tract conditions, making them indispensable for healthcare providers. Meanwhile, the HIDA Scan segment is rapidly gaining traction, characterizing it as the fastest-growing area in this market. This growing adoption is supported by an increased awareness of the benefits associated with HIDA scans, such as enhanced diagnostic accuracy.

Radiopharmaceuticals (Dominant) vs. HIDA Scan (Emerging)

Radiopharmaceuticals remain the dominant segment in the HIDA Scan Market, primarily due to their essential role in diagnostic imaging of liver diseases and gallbladder function. Their efficacy in providing clear and reliable imaging results has solidified their position among healthcare professionals. Conversely, the HIDA Scan segment is emerging rapidly, driven by growing clinical acceptance and technological advancements that enhance imaging capabilities. As hospitals and clinics increasingly recognize the value of HIDA scans in improving patient outcomes, this segment is poised to grow significantly, attracting investments aimed at expanding its accessibility and application in various medical settings.

By Indication: Cholecystitis (Largest) vs. Bile Duct Obstruction (Fastest-Growing)

In the HIDA Scan Market, the indication segment showcases a diverse array of conditions, with cholecystitis accounting for the largest share due to its prevalence in both acute and chronic forms. Following closely are bile duct obstruction and biliary atresia, as both conditions require precise imaging for effective diagnosis. The distribution among these indications highlights the significance of targeted imaging in managing gallbladder diseases and related disorders, thus driving the overall market growth as healthcare providers increasingly rely on HIDA scans for their diagnostic accuracy and effectiveness. As healthcare systems evolve, growth trends indicate a surge in the demand for HIDA scans, particularly in bile duct obstruction, which is identified as the fastest-growing segment. The increasing incidence of complications following surgeries and the need for postoperative assessments have further bolstered this segment. Additionally, advancements in imaging technology and the rising awareness among healthcare professionals regarding the benefits of HIDA scans in various indications contribute to the anticipated growth in the market, supporting enhanced patient outcomes and facilitating earlier interventions.

Cholecystitis (Dominant) vs. Biliary Atresia (Emerging)

Cholecystitis remains the dominant indication within the HIDA Scan Market, primarily due to its commonality and the established clinical protocols for diagnosis and treatment. Medical professionals favor HIDA scans for evaluating gallbladder function and detecting inflammation, which is crucial for determining treatment options. In contrast, biliary atresia, though recognized as an emerging indication, is gaining traction as diagnostic awareness grows. This condition significantly impacts pediatric populations, and the utilization of HIDA scans aids in the early detection and management of biliary complications. Both indications highlight the importance of targeted imaging strategies, addressing the specific needs of varied patient demographics.

By End User: Orthopedic Hospitals & Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the HIDA Scan Market, orthopedic hospitals and clinics hold the most significant share, establishing themselves as the dominant end user segment. This is attributed to the high volume of patients requiring advanced imaging for orthopedic conditions, which enhances the utilization of HIDA scans in treatment planning. Despite their leading position, diagnostic centers are rapidly capturing a substantial share, fueled by the increasing demand for accurate and timely imaging services across various healthcare settings. These centers are highly valued for their ability to deliver specialized imaging services efficiently. The growth trends within this segment indicate a promising future for both orthopedic hospitals and clinics as well as diagnostic centers. The technological advancements in HIDA scan equipment, along with a growing emphasis on early disease detection and health maintenance, drive shifts in demand. Additionally, the increasing focus on outpatient care and the expansion of diagnostic facilities contribute significantly to the scalability and adaptability of the HIDA scan market, ensuring sustained growth across different end user categories.

Orthopedic Hospitals & Clinics (Dominant) vs. Diagnostic Centers (Emerging)

Orthopedic hospitals and clinics are instrumental in the HIDA Scan Market, primarily because they focus on imaging that supports orthopedic diagnoses and surgical planning. Characterized by their specialized services, these establishments provide consistent demand for HIDA scans, driven by the need for precise imaging in diagnosing and treating musculoskeletal disorders. On the other hand, diagnostic centers represent an emerging segment that is increasingly recognized for versatility and accessibility. They are expanding rapidly due to technological innovations and a patient-centric approach, providing a broader range of imaging services and faster turnaround times. This makes them a preferred choice for many patients seeking prompt diagnostic care, complementing the traditional strengths of orthopedic clinics.

Get more detailed insights about HIDA Scan Market

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for HIDA scans, accounting for approximately 45% of the global share. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of liver diseases, and rising demand for diagnostic imaging. Regulatory support from agencies like the FDA further catalyzes market expansion, ensuring safety and efficacy in medical imaging technologies. The U.S. and Canada are the primary contributors to this market, with a strong focus on technological advancements and patient-centric healthcare solutions. The competitive landscape in North America is characterized by the presence of major players such as GE Healthcare, Siemens Healthineers, and Lantheus Medical Imaging. These companies are investing heavily in research and development to enhance imaging technologies and improve patient outcomes. The market is also witnessing collaborations and partnerships aimed at expanding product offerings and enhancing service delivery. This competitive environment fosters innovation and ensures that healthcare providers have access to the latest diagnostic tools.

Europe : Emerging Market Dynamics

Europe is the second-largest market for HIDA scans, holding approximately 30% of the global market share. The growth in this region is propelled by increasing healthcare expenditure, a rising aging population, and advancements in imaging technologies. Regulatory frameworks, such as the European Medical Device Regulation (MDR), are enhancing the safety and effectiveness of medical devices, thereby boosting market confidence. Countries like Germany and France are leading the market, driven by robust healthcare systems and high demand for diagnostic imaging solutions. The competitive landscape in Europe features key players like Siemens Healthineers and Philips Healthcare, which are at the forefront of innovation in imaging technologies. The presence of established healthcare institutions and a focus on research and development further strengthen the market. Additionally, collaborations between healthcare providers and technology firms are fostering the development of advanced imaging solutions, ensuring that Europe remains a vital player in the HIDA scan market.

Asia-Pacific : Rapidly Growing Healthcare Sector

Asia-Pacific is witnessing rapid growth in the HIDA scan market, accounting for approximately 20% of the global share. The region's expansion is driven by increasing healthcare investments, a growing population, and rising awareness of diagnostic imaging. Countries like China and India are leading this growth, supported by government initiatives aimed at improving healthcare access and quality. The regulatory environment is evolving, with efforts to streamline approvals for medical devices, which is expected to further boost market growth. The competitive landscape in Asia-Pacific is becoming increasingly dynamic, with both local and international players vying for market share. Companies such as Canon Medical Systems and Fujifilm Holdings are investing in advanced imaging technologies to cater to the growing demand. The presence of a large patient population and increasing healthcare spending are key factors driving competition, leading to innovations in imaging solutions that enhance diagnostic accuracy and patient care.

Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa region is gradually emerging in the HIDA scan market, holding approximately 5% of the global share. The growth is primarily driven by increasing healthcare investments, rising awareness of diagnostic imaging, and government initiatives aimed at improving healthcare infrastructure. Countries like South Africa and the UAE are leading this growth, with a focus on enhancing healthcare services and expanding access to advanced medical technologies. Regulatory bodies are working to establish frameworks that support the safe use of medical devices, which is crucial for market development. The competitive landscape in the Middle East and Africa is characterized by a mix of local and international players. Companies are increasingly focusing on partnerships and collaborations to enhance their market presence. The demand for advanced imaging solutions is growing, driven by an increasing burden of chronic diseases and a need for accurate diagnostics. This presents significant opportunities for growth and innovation in the HIDA scan market across the region.

HIDA Scan Market Regional Image

Key Companies in the HIDA Scan Market market include

Future Outlook

HIDA Scan Market Future Outlook

The HIDA Scan Market is projected to grow at an 11.2% CAGR from 2024 to 2035, driven by technological advancements, increasing prevalence of liver diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable HIDA scan devices for outpatient settings.
  • Partnerships with telemedicine platforms for remote diagnostics.
  • Expansion into emerging markets with tailored pricing strategies.

By 2035, the HIDA Scan Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

Market Segmentation

HIDA Scan Market Product Outlook

  • radiopharmaceuticals
  • HIDA Scan
  • others

HIDA Scan Market End User Outlook

  • orthopedic hospitals & clinics
  • diagnostic centers
  • others

HIDA Scan Market Indication Outlook

  • cholecystitis
  • bile duct obstruction
  • biliary atresia
  • postoperative complications
  • assessment of liver transplant
  • others

Report Scope

MARKET SIZE 20240.2224(USD Billion)
MARKET SIZE 20250.2473(USD Billion)
MARKET SIZE 20350.715(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)11.2% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in imaging technology enhance diagnostic accuracy in the HIDA Scan Market.
Key Market DynamicsTechnological advancements and regulatory changes drive growth in the HIDA Scan market, enhancing diagnostic capabilities and patient outcomes.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Market Highlights

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Leave a Comment

FAQs

What is the projected market valuation of the HIDA Scan Market by 2035?

The HIDA Scan Market is projected to reach a valuation of 0.715 USD Billion by 2035.

What was the market valuation of the HIDA Scan Market in 2024?

In 2024, the HIDA Scan Market had a valuation of 0.2224 USD Billion.

What is the expected CAGR for the HIDA Scan Market during the forecast period 2025 - 2035?

The expected CAGR for the HIDA Scan Market during the forecast period 2025 - 2035 is 11.2%.

Which companies are considered key players in the HIDA Scan Market?

Key players in the HIDA Scan Market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Lantheus Medical Imaging.

What are the primary product segments within the HIDA Scan Market?

The primary product segments include radiopharmaceuticals, HIDA Scan, and others, with HIDA Scan valued at 0.1112 USD Billion in 2024.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions